Cargando…

A relation between osteoclastogenesis inhibition and membrane-type estrogen receptor GPR30

Disruption of the cooperative balance between osteoblasts and osteoclasts causes various bone disorders, some of which are because of abnormal osteoclast recruitment. Osteoporosis, one of the bone disorders, is not effectively treated by currently available medicines. In addition to the development...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuhara, Masaaki, Tsukahara, Takao, Tomita, Kazuo, Furukawa, Minami, Miyawaki, Shouichi, Sato, Tomoaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614543/ https://www.ncbi.nlm.nih.gov/pubmed/28955981 http://dx.doi.org/10.1016/j.bbrep.2016.10.013

Ejemplares similares

PT547. 17alfa-estradiol prevents gamma-aminobutyric signaling dysfunction induced by repeated stress in the hippocampus associated with behavioral abnormalities via G-protein-coupled estrogen receptor in ovariectomized mice
por: Tsukahara, Takao, et al.
Publicado: (2016)

The effect of repeated stress on KCC2 and NKCC1 immunoreactivity in the hippocampus of female mice
por: Tsukahara, Takao, et al.
Publicado: (2016)

Reconsidering the roles of endogenous estrogens and xenoestrogens: the membrane estradiol receptor G protein-coupled receptor 30 (GPR30) mediates the effects of various estrogens
por: KADOKAWA, Hiroya, et al.
Publicado: (2018)

Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes
por: Ikeda, Yasumasa, et al.
Publicado: (2012)

G-protein Coupled Estrogen Receptor (GPER/GPR30) and Women's Health
por: Kim, Mi-Jin, et al.
Publicado: (2015)

The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation
por: Zhang, Zengli, et al.
Publicado: (2018)

The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo
por: Wei, W, et al.
Publicado: (2014)

GPR84 potently inhibits osteoclastogenesis and alleviates osteolysis in bone metastasis of colorectal cancer
por: Jian, Li, et al.
Publicado: (2023)

Polymorphisms of estrogen receptors, ERα and GPR30: association with breast cancer susceptibility and prognosis
por: Alves, Susana M, et al.
Publicado: (2010)

Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer
por: Jala, Venkatakrishna Rao, et al.
Publicado: (2012)

The G-Protein-Coupled Estrogen Receptor (GPER/GPR30) in Ovarian Granulosa Cell Tumors
por: Heublein, Sabine, et al.
Publicado: (2014)

GPR30, the Non-Classical Membrane G Protein Related Estrogen Receptor, Is Overexpressed in Human Seminoma and Promotes Seminoma Cell Proliferation
por: Chevalier, Nicolas, et al.
Publicado: (2012)

Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning
por: Mosca, Maria Giovanna, et al.
Publicado: (2021)

The Cell Surface Estrogen Receptor, G Protein- Coupled Receptor 30 (GPR30), is Markedly Down Regulated During Breast Tumorigenesis
por: Poola, Indira, et al.
Publicado: (2008)

GPR30, but not estrogen receptor-α, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol
por: Yates, Melissa A, et al.
Publicado: (2010)

A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9
por: Ulitzky, Laura, et al.
Publicado: (2016)

Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
por: Tutzauer, Julia, et al.
Publicado: (2020)

Roles of ERβ and GPR30 in Proliferative Response of Human Bladder Cancer Cell to Estrogen
por: Huang, Weiren, et al.
Publicado: (2015)

The positivity of G-protein-coupled receptor-30 (GPR 30), an alternative estrogen receptor is not different between type 1 and type 2 endometrial cancer
por: Wan, Jiayi, et al.
Publicado: (2017)

Madecassoside inhibits estrogen deficiency‐induced osteoporosis by suppressing RANKL‐induced osteoclastogenesis
por: Wang, Qingqing, et al.
Publicado: (2018)

The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer
por: Kolkova, Zuzana, et al.
Publicado: (2012)

Genetic Variants of GPER/GPR30, a Novel Estrogen-Related G Protein Receptor, Are Associated with Human Seminoma
por: Chevalier, Nicolas, et al.
Publicado: (2014)

Estrogens Induce Rapid Cytoskeleton Re-Organization in Human Dermal Fibroblasts via the Non-Classical Receptor GPR30
por: Carnesecchi, Julie, et al.
Publicado: (2015)

Estrogen-Mediated Renoprotection following Cardiac Arrest and Cardiopulmonary Resuscitation Is Robust to GPR30 Gene Deletion
por: Hutchens, Michael P., et al.
Publicado: (2014)

Synergistic effect between LH and estrogen in the acceleration of cumulus expansion via GPR30 and EGFR pathways
por: Liu, Jie, et al.
Publicado: (2020)

Aspirin prevents estrogen deficiency-induced bone loss by inhibiting osteoclastogenesis and promoting osteogenesis
por: Chang, Yongyun, et al.
Publicado: (2023)

The G-Protein Coupled Estrogen Receptor (GPER/GPR30) is a Gonadotropin Receptor Dependent Positive Prognosticator in Ovarian Carcinoma Patients
por: Heublein, Sabine, et al.
Publicado: (2013)

Effects of estrogen receptor GPR30 agonist G1 on neuronal apoptosis and microglia polarization in traumatic brain injury rats
por: Pan, Meng-Xian, et al.
Publicado: (2018)

Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers
por: Hernández-Silva, Christian David, et al.
Publicado: (2020)

Synthesis and Characterization of Tricarbonyl-Re/Tc(I) Chelate Probes Targeting the G Protein-Coupled Estrogen Receptor GPER/GPR30
por: Burai, Ritwik, et al.
Publicado: (2012)

GPR109A mediates the effects of hippuric acid on regulating osteoclastogenesis and bone resorption in mice
por: Chen, Jin-Ran, et al.
Publicado: (2021)

In vivo Effects of a GPR30 Antagonist
por: Dennis, Megan K., et al.
Publicado: (2009)

Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression
por: Akimoto, Taishi, et al.
Publicado: (2018)

GPR30-mediated non-classic estrogen pathway in mast cells participates in endometriosis pain via the production of FGF2
por: Xu, Xinxin, et al.
Publicado: (2023)

G-Protein Coupled Receptor 30 (GPR30): A Novel Regulator of Endothelial Inflammation
por: Chakrabarti, Subhadeep, et al.
Publicado: (2012)

MDH2 Stimulated by Estrogen-GPR30 Pathway Down-Regulated PTEN Expression Promoting the Proliferation and Invasion of Cells in Endometrial Cancer()()
por: Zhuang, Yan, et al.
Publicado: (2017)

GPR125 positively regulates osteoclastogenesis potentially through AKT-NF-κB and MAPK signaling pathways
por: Tang, Chen-Yi, et al.
Publicado: (2022)

Lactulose Suppresses Osteoclastogenesis and Ameliorates Estrogen Deficiency-Induced Bone Loss in Mice
por: Chen, Xiao, et al.
Publicado: (2019)

445 Inhibition of GPR30 Reveals Putative Genes Involved in the Pathogenesis of Inflammatory Breast Cancer
por: Carrion-Laureano, Melanie, et al.
Publicado: (2022)

Inhibition of GPR30 sensitized gefitinib to NSCLC cells via regulation of epithelial-mesenchymal transition
por: Yang, Xiaomin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7uae4clcmtk25tbihsia23f303